官方服务：
资源简介：
Ovarian Cancer Genetic Testing
应用场景：
创建时间：
2024-04-24
相关数据集
Global DNA hypomethylation in ovarian cancer. Global DNA hypomethylation in ovarian cancer
This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
NIAID Data Ecosystem70
Multi-omic analysis of homologous recombination deficient, end-stage ovarian cancer [Methylation]. Multi-omic analysis of homologous recombination deficient, end-stage ovarian cancer [Methylation]
High grade serous ovarian cancer (HGSC) is frequently characterized by homologous recombination (HR) DNA repair deficiency, and while most such tumors are sensitive to initial treatment, acquired resi
NIAID Data Ecosystem40
Re-expression of SMARCA4/BRG1 in Small Cell Carcinoma of Ovary, Hypercalcemic Type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism [ATAC-seq]
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and aggressive form of ovarian cancer. SCCOHT tumors have inactivating mutations in SMARCA4 (BRG1), one of the two mutually exc
NIAID Data Ecosystem20
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) cell line H3K27ac CUT&RUN
Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT) is a rare form of ovarian cancer affecting young women and girls. Survival rates remain poor despite aggressive treatment of these patient
NIAID Data Ecosystem60
Additional file 1 of Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
Additional file 1. Table S1. Amplification primers and sequencing primers for Pyrosequencing. Table S2. Primers sequence for QRT-PCR. Table S3. Pathway analysis of different methylation sites between
Figshare2024-02-19 更新30
